Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Intellectual disability-polydactyly-uncombable hair syndrome is a multiple congenital anomalies/dysmorphic syndrome characterized by intellectual disability, postaxial polydactyly, phalangeal hypoplasia, 2-3 toe syndactyly, uncombable hair and facial dysmorphism (including frontal bossing, hypotelorism, narrow palpebral fissures, nasal bridge and lips, prominent nasal root, large abnormal ears with prominent antihelix, poorly folded helix, underdeveloped lobule and antitragus, and micrognathia evolving into prognatism). Cryptorchidism, conductive hearing loss and progressive thoracic kyphosis were also reported.
Biomarker and diagnostic research for intellectual disability-polydactyly-uncombable hair syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for intellectual disability-polydactyly-uncombable hair syndrome.
152 publications have been identified in PubMed for intellectual disability-polydactyly-uncombable hair syndrome. Research spans Review / Meta-Analysis (56%), Case Report / Case Series (18%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 85 | 56% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:32 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies |
27 |
18% |
Laboratory research | 23 | 15% |
Testing and diagnosis research | 7 | 5% |
Disease patterns and progression | 6 | 4% |
Other research | 2 | 1% |
Clinical study results | 2 | 1% |
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *American journal of human genetics*. [Basic Science / Preclinical]
Rautiainen N (2026). [PMID: 41074678](https://pubmed.ncbi.nlm.nih.gov/41074678/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Du C (2026). [PMID: 41846525](https://pubmed.ncbi.nlm.nih.gov/41846525/). *Journal of pediatric endocrinology & metabolism : JPEM*. [Case Report / Case Series]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology*. [Review / Meta-Analysis]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Rabin R (2026). [PMID: 41531333](https://pubmed.ncbi.nlm.nih.gov/41531333/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Dri J (2025). [PMID: 40168358](https://pubmed.ncbi.nlm.nih.gov/40168358/). *Archivos argentinos de pediatria*. [Case Report / Case Series]
Jachiet V (2025). [PMID: 40476413](https://pubmed.ncbi.nlm.nih.gov/40476413/). *La Revue du praticien*. [Review / Meta-Analysis]
Dotan A (2025). [PMID: 39931017](https://pubmed.ncbi.nlm.nih.gov/39931017/). *Harefuah*. [Review / Meta-Analysis]
Kaul A (2025). [PMID: 40915300](https://pubmed.ncbi.nlm.nih.gov/40915300/). *The Lancet. Rheumatology*. [Review / Meta-Analysis]